Merck & Co. (MRK) has agreed to sell CSL Ltd.'s (CSL.AU) seasonal flu vaccine in the U.S. for a six-year period starting next fall, getting...
Fred Hassan, chief executive of Schering-Plough Corp. (SGP), believes the future leaders of the pharmaceutical industry need to focus on...
Boehringer Ingelheim Gmbh agreed to acquire animal health assets that Wyeth (WYE) is required to sell to win regulatory approval for its $68...
Merck & Co. (MRK) and Schering-Plough Corp. (SGP), makers of the controversial cholesterol drug Vytorin, spent roughly $60 million over four...
Centocor Ortho Biotech Products LP, a unit of Johnson & Johnson (JNJ), received a complete response letter from the Food and Drug...
Dainippon Sumitomo Pharma Co. (4506.TO) is in the final stage of talks to buy U.S. pharmaceutical maker Sepracor Inc. (SEPR), a person familiar...
(Updates to add comment from company, background) DOW JONES NEWSWIRES A federal court in New Jersey denied Schering-Plough Corp. (SGP) a $473...
A federal court in New Jersey denied Schering-Plough Corp. (SGP) a $473 million refund in connection with two transactions in which the drug maker...
(Updated throughout with details on management moves, analyst comments.) By Thomas Gryta and Jon Kamp Of DOW JONES NEWSWIRES Merck & Co. (MRK...
Merck & Co. (MRK) named the management team that will be in place after the drug maker closes its acquisition of Schering Plough Corp. (SGP...
French drug maker Sanofi-Aventis S.A. (SAN.FR) Sunday said an experimental drug designed to stop blood clots in patients with serious heart...
Please disregard the headline "FDA OKs Saphris For Schizophrenia and Bipolar Disorder" published at 10:45 a.m. EDT. The news was reported in full...
The Food and Drug Administration gave final approval to Schering-Plough Corp.'s (SGP) asenapine, a treatment for both schizophrenia and bipolar...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
News
Market Data
Register to chat with like-minded investors on our interactive forums.
